Literature DB >> 33326127

Fecal microbiota transplantation in patients with acute and chronic graft-versus-host disease-spectrum of responses and safety profile. Results from a prospective, multicenter study.

Jaroslaw Bilinski1, Karol Lis1, Agnieszka Tomaszewska1, Pawel Grzesiowski2, Tomasz Dzieciatkowski3,4, Martyna Tyszka1, Ewa Karakulska-Prystupiuk1, Piotr Boguradzki1, Magdalena Tormanowska5, Kazimierz Halaburda5, Anna Waszczuk-Gajda1, Wieslaw Wiktor-Jedrzejczak1, Grzegorz W Basak1.   

Abstract

Entities:  

Year:  2021        PMID： 33326127     DOI： 10.1002/ajh.26077

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  8 in total

1.  Safety and efficacy of fecal microbiota transplantation in the treatment of graft-versus-host disease.

Authors:  Xiaoying Qiao; Jarosław Biliński; Leyi Wang; Tianyu Yang; Rongmu Luo; Yi Fu; Guibin Yang
Journal:  Bone Marrow Transplant       Date:  2022-09-27       Impact factor: 5.174

Review 2.  Restoration of the Original Inhabitants: A Systematic Review on Fecal Microbiota Transplantation for Graft-Versus-Host Disease.

Authors:  Mohamad S Alabdaljabar; Hafiz M Aslam; Sindhusha Veeraballi; Faizan A Faizee; Batool H Husain; Shumaila M Iqbal; Shahrukh K Hashmi
Journal:  Cureus       Date:  2022-04-06

Review 3.  The Role of Fecal Microbiota Transplantation in the Treatment of Acute Graft-versus-Host Disease.

Authors:  Jarosław Biliński; Marcin Jasiński; Grzegorz W Basak
Journal:  Biomedicines       Date:  2022-04-01

4.  Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.

Authors:  Fengqin Su; Yi Luo; Jian Yu; Jimin Shi; Yanmin Zhao; Mengni Yan; He Huang; Yamin Tan
Journal:  Eur J Med Res       Date:  2021-04-28       Impact factor: 2.175

5.  Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study.

Authors:  Walter Spindelboeck; Bettina Halwachs; Nadine Bayer; Bianca Huber-Krassnitzer; Eduard Schulz; Barbara Uhl; Lukas Gaksch; Stefan Hatzl; Victoria Bachmayr; Lisa Kleissl; Patrizia Kump; Alexander Deutsch; Georg Stary; Hildegard Greinix; Gregor Gorkiewicz; Christoph Högenauer; Peter Neumeister
Journal:  Ther Adv Hematol       Date:  2021-12-21

Review 6.  Microbiota medicine: towards clinical revolution.

Authors:  Prisca Gebrayel; Carole Nicco; Souhaila Al Khodor; Jaroslaw Bilinski; Elisabetta Caselli; Elena M Comelli; Markus Egert; Cristina Giaroni; Tomasz M Karpinski; Igor Loniewski; Agata Mulak; Julie Reygner; Paulina Samczuk; Matteo Serino; Mariusz Sikora; Annalisa Terranegra; Marcin Ufnal; Romain Villeger; Chantal Pichon; Peter Konturek; Marvin Edeas
Journal:  J Transl Med       Date:  2022-03-07       Impact factor: 5.531

Review 7.  The Role of the Crosstalk Between Gut Microbiota and Immune Cells in the Pathogenesis and Treatment of Multiple Myeloma.

Authors:  Marcin Jasiński; Jarosław Biliński; Grzegorz W Basak
Journal:  Front Immunol       Date:  2022-03-31       Impact factor: 7.561

Review 8.  Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation.

Authors:  Sergii Tkach; Andrii Dorofeyev; Iurii Kuzenko; Nadiya Boyko; Tetyana Falalyeyeva; Luigi Boccuto; Emidio Scarpellini; Nazarii Kobyliak; Ludovico Abenavoli
Journal:  Medicina (Kaunas)       Date:  2022-01-06       Impact factor: 2.430
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.